XNCR FY 2013 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$883M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M+6.8% YoY

Gross Profit

-$7M-67.1% margin

Operating Income

-$11M-103.4% margin

Net Income

-$60M-592.4% margin

EPS (Diluted)

$-1.92

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$7M

Stock-Based Comp.

$198,000

Balance Sheet

Total Assets

$87M

Total Liabilities

$14M

Stockholders' Equity

$74M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$10M	+6.8%
Gross Profit	-$7M	-$3M	-117.2%
Operating Income	-$11M	-$6M	-68.9%
Net Income	-$60M	-$9M	-601.2%